Amgen (AMGN UW)

Analysis

Health Care • United States

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures, and markets medicines for grievous illnesses. The Company focuses on human therapeutics and concentrates on innovating novel medicines based on cellular and molecular biology.

Refresh

bullish•Amgen Inc

•03 May 2026 02:47

Primer: Amgen Inc (AMGN US) - May 2026

Amgen is strategically navigating a period of transition, balancing the maturation of key blockbuster drugs with growth from recent acquisitions...

αSK Primers

182 Views

bullish•Amgen

•03 May 2026 02:47

Primer: Amgen (AMGN UW) - May 2026

Amgen's diversified portfolio, with 17 products annualizing over $1 billion in sales, provides a stable revenue base to offset patent...

αSK Primers

124 Views

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00